Clinical Research Directory

Inclusion Criteria: UVEITIS Patients: * Adult patients (≥ 18 years); * Non-infectious uveitis; * Intermediate, posterior or panuveitis; * Inflammatory activity requiring treatment with either one or more of the followings: * Systemic corticosteroids or periocular or intravitreal injections of corticosteroids; * Immunosuppressants: methotrexate, azathioprine, cyclosporine, etc.; * Biotherapy: infliximab, adalimumab, tocilizumab; * Patients with health insurance; * Written Informed consent obtained at enrolment in the study. Control patients: * Adult patients (≥ 18 years); * Scheduled patients ( Non-urgente procedure) for cataract or vitreoretinal surgery; * Patients with health insurance; * Written Informed consent obtained at enrolment in the study. Exclusion Criteria: Uveitis Patients: * Isolated anterior uveitis ; * Inactive disease defined as: * Absence of inflammatory chorioretinal and/or inflammatory retinal vascular lesion; * Anterior chamber cell grade\< 0.5+; * Vitreous haze grade \<0.5+; * Pregnant or breastfeeding woman at the inclusion visit; * Patient under legal protection (" curatelle " or " tutelle "); * Patient denied freedom by a legal or administrative order. Control patients: * Pregnant or breastfeeding woman; * Unscheduled (urgent) cataract or vitreoretinal surgery; * Patient under legal protection (" curatelle " or " tutelle "); * Patient denied freedom by a legal or administrative order.